Programa HAS de Acceso Anticipado: Tendencias positivas después de dos años
La Haute Autorité de Santé (HAS) ha presentado recientemente un resumen de dos años de su programa Early Access. Los
Pricing and Reimbursement in Germany – Possibility of price increases for legacy products
In an effort to control rising cost Germany introduced both a price freeze preventing price increases on legacy products effective
